CCNI
Cyclin-I
Also known as: CCNI_HUMAN, CCNI1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14094
- Gene
- CCNI
- Ensembl
- ENSG00000118816
- Chromosome
- 4
- Canonical length
- 377 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Golgi apparatus
OverviewNCBI Gene
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin shows the highest similarity with cyclin G. The transcript of this gene was found to be expressed constantly during cell cycle progression. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
377 residues, UniProt reviewed canonical sequence.
>Q14094|CCNI
1 MKFPGPLENQ RLSFLLEKAI TREAQMWKVN VRKMPSNQNV SPSQRDEVIQ WLAKLKYQFN
61 LYPETFALAS SLLDRFLATV KAHPKYLSCI AISCFFLAAK TVEEDERIPV LKVLARDSFC
121 GCSSSEILRM ERIILDKLNW DLHTATPLDF LHIFHAIAVS TRPQLLFSLP KLSPSQHLAV
181 LTKQLLHCMA CNQLLQFRGS MLALAMVSLE MEKLIPDWLS LTIELLQKAQ MDSSQLIHCR
241 ELVAHHLSTL QSSLPLNSVY VYRPLKHTLV TCDKGVFRLH PSSVPGPDFS KDNSKPEVPV
301 RGTAAFYHHL PAASGCKQTS TKRKVEEMEV DDFYDGIKRL YNEDNVSENV GSVCGTDLSR
361 QEGHASPCPP LQPVSVMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCNI can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 297 nTPM
Expression across tissuesHPA
Tissue
- ovary: 297 nTPM
- cerebellum: 286 nTPM
- blood vessel: 285 nTPM
- thyroid gland: 256 nTPM
- epididymis: 235 nTPM
- cerebral cortex: 227 nTPM
Single-cell type
- esophageal apical cells: 2,300 nCPM
- oocytes: 1,124 nCPM
- undifferentiated spermatogonia: 1,043 nCPM
- parietal cells: 921 nCPM
- decidual stromal cells: 911 nCPM
- kupffer cells: 884 nCPM
Immune cell
- eosinophil: 238 nTPM
- naive CD4 T-cell: 166 nTPM
- basophil: 162 nTPM
- memory CD4 T-cell: 158 nTPM
- naive B-cell: 154 nTPM
- T-reg: 150 nTPM
Brain region
- cerebellum: 485 nTPM
- white matter: 417 nTPM
- cerebral cortex: 406 nTPM
- midbrain: 360 nTPM
- thalamus: 359 nTPM
- basal ganglia: 353 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CCNI.
Disease | ImmuneIEDB
Conditions an epitope on CCNI was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.83
- gnomAD missense Z
- 0.95
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCNI in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCNI as an antibody target. Whether an autoantibody or antibody against CCNI could matter depends on whether native CCNI is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCNI is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCNI as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...